203 related articles for article (PubMed ID: 20223504)
1. Protective value of a folkloric medicinal plant extract against mortality and hemorrhage in a life-threatening renal trauma model.
Tokgöz H; Karakaya K; Hanci V; Abduşoğlu M; Erol B; Türksoy O; Akduman B; Mungan NA
Urology; 2010 Jun; 75(6):1515.e9-14. PubMed ID: 20223504
[TBL] [Abstract][Full Text] [Related]
2. Hemostatic role of a folkloric medicinal plant extract in a rat partial nephrectomy model: controlled experimental trial.
Huri E; Akgül T; Ayyildiz A; Ustün H; Germiyanoğlu C
J Urol; 2009 May; 181(5):2349-54. PubMed ID: 19303089
[TBL] [Abstract][Full Text] [Related]
3. Cross-linked matrix tissue sealant protects against mortality and hemorrhage in an acute renal injury model in heparinized rats.
Petratos PB; Ito K; Felsen D; Poppas D
J Urol; 2002 May; 167(5):2222-4. PubMed ID: 11956482
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a new hemostatic agent Ankaferd Blood Stopper in experimental liver laceration.
Karakaya K; Ucan HB; Tascilar O; Emre AU; Cakmak GK; Irkorucu O; Ankarali H; Comert M
J Invest Surg; 2009; 22(3):201-6. PubMed ID: 19466658
[TBL] [Abstract][Full Text] [Related]
5. The efficacy of Ankaferd Blood Stopper in antithrombotic drug-induced primary and secondary hemostatic abnormalities of a rat-bleeding model.
Kosar A; Cipil HS; Kaya A; Uz B; Haznedaroglu IC; Goker H; Ozdemir O; Ercetin S; Kirazli S; Firat HC
Blood Coagul Fibrinolysis; 2009 Apr; 20(3):185-90. PubMed ID: 19657315
[TBL] [Abstract][Full Text] [Related]
6. Haemostatic role and histopathological effects of a new haemostatic agent in a rat bladder haemorrhage model: an experimental trial.
Kilic O; Gonen M; Acar K; Yurdakul T; Avunduk MC; Esen HH; Oz M
BJU Int; 2010 Jun; 105(12):1722-5. PubMed ID: 19849692
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of BloodSTOP iX, surgicel, and gelfoam in rat models of active bleeding from partial nephrectomy and aortic needle injury.
Ferretti L; Qiu X; Villalta J; Lin G
Urology; 2012 Nov; 80(5):1161.e1-6. PubMed ID: 22921708
[TBL] [Abstract][Full Text] [Related]
8. Hemostatic efficacy of Ankaferd Blood Stopper in a swine bleeding model.
Bilgili H; Kosar A; Kurt M; Onal IK; Goker H; Captug O; Shorbagi A; Turgut M; Kekilli M; Kurt OK; Kirazli S; Aksu S; Haznedaroglu IC
Med Princ Pract; 2009; 18(3):165-9. PubMed ID: 19349716
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the hemostatic and histopathological effects of Ankaferd Blood Stopper in experimental liver injury in rats.
Satar NY; Akkoc A; Oktay A; Topal A; Inan K
Blood Coagul Fibrinolysis; 2013 Jul; 24(5):518-24. PubMed ID: 23399904
[TBL] [Abstract][Full Text] [Related]
10. Hemostatic efficacy of folkloric medicinal plant extract in a rat skin bleeding model.
Kose R; Sogut O; Demir T; Koruk I
Dermatol Surg; 2012 May; 38(5):760-6. PubMed ID: 22268820
[TBL] [Abstract][Full Text] [Related]
11. Comparison of a new hemostatic agent to current combat hemostatic agents in a Swine model of lethal extremity arterial hemorrhage.
Ward KR; Tiba MH; Holbert WH; Blocher CR; Draucker GT; Proffitt EK; Bowlin GL; Ivatury RR; Diegelmann RF
J Trauma; 2007 Aug; 63(2):276-83; discussion 283-4. PubMed ID: 17693824
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of Ankaferd Blood Stopper in heparin-induced hemostatic abnormality in a rat epistaxis model.
Iynen I; Sogut O; Kose R
Otolaryngol Head Neck Surg; 2011 Nov; 145(5):840-4. PubMed ID: 21750339
[TBL] [Abstract][Full Text] [Related]
13. Biphasic effects of ankaferd blood stopper on renal tubular apoptosis in the rat partial nephrectomy model representing distinct levels of hemorrhage.
Huri E; Haznedaroglu IC; Akgul T; Astarci M; Ustun H; Germiyanoulu C
Saudi Med J; 2010 Aug; 31(8):864-8. PubMed ID: 20714682
[TBL] [Abstract][Full Text] [Related]
14. Determination of efficacy of new hemostatic dressings in a model of extremity arterial hemorrhage in swine.
Kheirabadi BS; Scherer MR; Estep JS; Dubick MA; Holcomb JB
J Trauma; 2009 Sep; 67(3):450-9; discussion 459-60. PubMed ID: 19741385
[TBL] [Abstract][Full Text] [Related]
15. New coagulant agent (ankaferd blood stopper) for open hemorrhages in hemophilia with inhibitor.
Öner AF; Doğan M; Kaya A; Sal E; Bektaş MS; Yesilmen O; Ayhan H; Acikgoz M
Clin Appl Thromb Hemost; 2010 Dec; 16(6):705-7. PubMed ID: 19528064
[TBL] [Abstract][Full Text] [Related]
16. Hemostatic efficacy of a traditional medicinal plant extract (Ankaferd Blood Stopper) in bleeding control.
Sogut O; Erdogan MO; Kose R; Boleken ME; Kaya H; Gokdemir MT; Ozgonul A; Iynen I; Albayrak L; Dokuzoglu MA
Clin Appl Thromb Hemost; 2015 May; 21(4):348-53. PubMed ID: 24057394
[TBL] [Abstract][Full Text] [Related]
17. First clinical experience of Ankaferd BloodStopper as a hemostatic agent in partial nephrectomy.
Huri E; Akgül T; Ayyildiz A; Bağcioğlu M; Germiyanoğlu C
Kaohsiung J Med Sci; 2010 Sep; 26(9):493-5. PubMed ID: 20837346
[TBL] [Abstract][Full Text] [Related]
18. Use of Ankaferd Blood Stopper as a hemostatic agent: a clinical experience.
Baykul T; Alanoglu EG; Kocer G
J Contemp Dent Pract; 2010 Jan; 11(1):E088-94. PubMed ID: 20098971
[TBL] [Abstract][Full Text] [Related]
19. Assessment of topical hemostats in a renal hemorrhage model in heparinized rats.
Tuthill DD; Bayer V; Gallagher AM; Drohan WN; MacPhee MJ
J Surg Res; 2001 Feb; 95(2):126-32. PubMed ID: 11162035
[TBL] [Abstract][Full Text] [Related]
20. A new practical alternative for the control of sternal bleeding during cardiac surgery: Ankaferd Blood Stopper.
Ergenoglu MU; Yerebakan H; Kucukaksu DS
Heart Surg Forum; 2010 Dec; 13(6):E379-80. PubMed ID: 21169147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
